T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in T2 Biosystems, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +2 vs. Q2 2024
- Shares held
- 2.15M
- −120.5K (−5.3%) vs. Q2 2024
- Total value
- $4.24M
- −$7.89M (−65.1%) vs. Q2 2024
- New holders
- 3
- 5 more added
- Sold out
- 1
- 6 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TTOO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 2 | $0 |
| Q4 2025 | 2 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 26 | $365.9K |
| Q3 2024 | 21 | $4.24M |
| Q2 2024 | 21 | $12.6M |
| Q1 2024 | 19 | $519.8K |
| Q4 2023 | 21 | $1.37M |
| Q3 2023 | 44 | $4.06M |
| Q2 2023 | 32 | $451.5K |
| Q1 2023 | 34 | $1.55M |
| Q4 2022 | 27 | $667.5K |
| Q3 2022 | 62 | $2.79M |
| Q2 2022 | 68 | $3.07M |
| Q1 2022 | 76 | $7.97M |
| Q4 2021 | 79 | $9.92M |
| Q3 2021 | 79 | $21.1M |
| Q2 2021 | 84 | $33.0M |
| Q1 2021 | 84 | $42.6M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding T2 Biosystems, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 1 | $2 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 1 | $2 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 3 | $6 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 14 | $28 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 56 | $110 | 0.00% | −72−56.3% | Reduced |
| Barclays PLC | 101 | $199 | 0.00% | +101 | New |
| Advisor Group Holdings, Inc. | 205 | $404 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 289 | $569 | 0.00% | −721−71.4% | Reduced |
| CWM, LLC | 310 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,399 | $4.73K | 0.00% | −5,268−68.7% | Reduced |
| Royal Bank of Canada | 4,001 | $8.00K | 0.00% | +1,146+40.1% | Added |
| Goldman Sachs Group Inc | 14,750 | $29.1K | 0.00% | +45+0.3% | Added |
| Northern Trust Corp | 27,142 | $53.5K | 0.00% | −11,737−30.2% | Reduced |
| Millennium Management LLC | 39,140 | $77.1K | 0.00% | +39,140 | New |
| Susquehanna International Group, LLP | 45,481 | $89.6K | 0.00% | +3,817+9.2% | Added |
| State Street Corp | 63,743 | $125.6K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 76,827 | $151.3K | 0.00% | +76,827 | New |
| Geode Capital Management, LLC | 90,880 | $179.2K | 0.00% | −39,509−30.3% | Reduced |
| Vanguard Group Inc | 390,368 | $769.0K | 0.00% | +77,667+24.8% | Added |
| Armistice Capital, LLC | 1,396,000 | $2.75M | 0.07% | −262,000−15.8% | Reduced |
| International Assets Investment Management, LLC | 65 | – | – | +32+97.0% | Added |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| JJJ Advisors Inc. | – | – | – | – | Not filed |